Page last updated: 2024-09-04

fidarestat and sb 239063

fidarestat has been researched along with sb 239063 in 1 studies

Compound Research Comparison

Studies
(fidarestat)
Trials
(fidarestat)
Recent Studies (post-2010)
(fidarestat)
Studies
(sb 239063)
Trials
(sb 239063)
Recent Studies (post-2010) (sb 239063)
9733384035

Protein Interaction Comparison

ProteinTaxonomyfidarestat (IC50)sb 239063 (IC50)
Mitogen-activated protein kinase 13Homo sapiens (human)0.044
Epidermal growth factor receptorHomo sapiens (human)0.083
Tyrosine-protein kinase LckHomo sapiens (human)0.018
Protein kinase C alpha typeHomo sapiens (human)0.083
Mitogen-activated protein kinase 9Homo sapiens (human)0.005
Mitogen-activated protein kinase 12Homo sapiens (human)0.044
Mitogen-activated protein kinase 11Homo sapiens (human)0.044
Mitogen-activated protein kinase 14Homo sapiens (human)0.0415

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agthong, S; Middlemas, AB; Price, SA; Tomlinson, DR1

Other Studies

1 other study(ies) available for fidarestat and sb 239063

ArticleYear
Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase.
    Diabetes, 2004, Volume: 53, Issue:7

    Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Activation; Enzyme Inhibitors; Ganglia, Spinal; Imidazoles; Imidazolidines; Insulin; Male; Mitogen-Activated Protein Kinases; Motor Neurons; Neural Conduction; Neurons, Afferent; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Wistar; Spinal Cord; Time Factors; Tissue Distribution

2004